Finance

Lists
CTXR:NASDAQ
Citius Pharmaceuticals Inc
$0.59
-2.18%
(-0.013) 1D
Sep 4, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTXR...
Open
$0.60
High
$0.61
Low
$0.58
Mkt. cap
16.19M
Avg. vol.
833.21K
Volume
299.63K
52-wk high
$2.19
52-wk low
$0.47
EPS
-$2.13
Beta
1.00
Shares outstanding
27.45M
No. of employees
23
Open
$0.60
High
$0.61
Low
$0.58
Mkt. cap
16.19M
Avg. vol.
833.21K
Volume
299.63K
52-wk high
$2.19
52-wk low
$0.47
EPS
-$2.13
Beta
1.00
Shares outstanding
27.45M
No. of employees
23
News stories
From web sources and news partners
About Citius Pharmaceuticals Inc
CEO-
Employees23
Founded2007
HeadquartersCranford, New Jersey, United States
SectorPharmaceutical industry
Websitecitiuspharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to CTXR in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CTXR in the last 3 months
Highest
Current $0.59
$4.00 (+580.62%)
Average
$4.00 (+580.62%)
Lowest
$4.00 (+580.62%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Maintained
$4.00
+580.6%
08/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
3.94M
1.67M
1.49M
Cost of goods sold
-
789.21K
328.88K
491.84K
Cost of revenue
-
789.21K
328.88K
491.84K
Research and development expenses
1.64M
1.60M
1.63M
1.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.80M
10.00M
30.18M
9.96M
Operating expense
8.44M
11.60M
31.81M
11.01M
Total operating expenses
8.44M
12.39M
32.14M
11.51M
Operating income
-8.44M
-8.45M
-30.47M
-10.01M
Other non operating income
-
-
-
-
EBT including unusual items
-8.48M
-9.13M
-28.34M
-12.03M
EBT excluding unusual items
-8.48M
-8.56M
-30.45M
-10.31M
Income tax expense
264.24K
264.24K
-231.21K
-107.35K
Effective tax rate
-3.12%
-2.89%
0.82%
0.89%
Other operating expenses
-
-
-
-
Net income
-7.96M
-8.22M
-21.23M
-8.86M
Net profit margin
-
-208.43%
-1,273.39%
-593.31%
Earnings per share
-0.11
-
-
-0.34
Interest and investment income
53.42K
45.10K
53.58K
116.69K
Interest expense
-95.52K
-155.54K
-33.03K
-411.22K
Net interest expenses
-42.10K
-110.44K
20.55K
-294.53K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.44M
-7.87M
-29.90M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps